Testing a new drug for allergic eye disease (AKC)
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a new medication called DFL24498 for people with atopic keratoconjunctivitis (AKC), a severe allergic eye condition. The goal is to see if it reduces itching, discomfort, and eye redness safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have been diagnosed with AKC in both eyes and have another allergic condition like eczema, asthma, or hay fever.
- Your eye itching is at least 50 on a 0-to-100 scale.
- Your eyes have some staining from dye and redness that are at least mild.
- You have symptoms like itching, tearing, discomfort, light sensitivity, and mucus discharge that add up to a score of 5 or more.
- If you could become pregnant, you must have a negative pregnancy test and use birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new eye drop called DFL24498 to see if it helps people with dry eye disease. You may qualify if your dry eye is moderate to severe and other treatments haven't worked well for you.
This study compares two versions of an experimental drug called 611 to see how they work in the body. It's for healthy volunteers to help find the best formulation for future treatments.
This trial tests a new eye drop, Drop 0.4%, for people with dry eye. It includes both people who wear contact lenses and those who don’t, to see if the drop is safe and helps with symptoms.
This trial tests an investigational eye drop called TL-925 to see if it can treat allergic conjunctivitis (eye allergies). If you have a history of eye allergies and a positive allergy skin test, you may be able to join.
This trial tests a new eye drop called RCI001 to see if it works better than a placebo for people with dry eye. You may be able to join if you have had dry eye for at least 6 months and have certain signs of dry eye during exams.
This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.
Hear when a new Atopic Keratoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.